Cargando…

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma

Cancer stem cells are regarded as the cause of tumour formation and recurrence in nasopharyngeal carcinoma (NPC). However, ideal surface markers for stem cells in NPC remain unidentified. In the present study, we investigated the expression of CD133, Nanog and Sox2 in the nasopharyngeal carcinoma ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHUANG, HUI-WEN, MO, TING-TING, HOU, WEI-JIAN, XIONG, GUAN-XIA, ZHU, XIAO-LIN, FU, QING-LING, WEN, WEI-PING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729244/ https://www.ncbi.nlm.nih.gov/pubmed/23604326 http://dx.doi.org/10.3892/or.2013.2408

Ejemplares similares

Study on the Biological Characteristics of CD133(+) Cells Interfered by RNA Interference in Gastric Cancer
por: Yu, Ji-wei, et al.
Publicado: (2014)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line
por: HAN, YONG, et al.
Publicado: (2015)

Emerging roles of MiR-133a in human cancers
por: Hua, Yu-Ting, et al.
Publicado: (2021)

CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy
por: Li, Jian, et al.
Publicado: (2016)

Silencing of Btbd7 Inhibited Epithelial–Mesenchymal Transition and Chemoresistance in CD133(+) Lung Carcinoma A549 Cells
por: Fang, Li-Zhou, et al.
Publicado: (2017)

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
por: Chen, Wei-Ching, et al.
Publicado: (2015)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells
por: Ge, Yanshan, et al.
Publicado: (2018)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Biochemical and biological characterization of exosomes containing prominin-1/CD133
por: Rappa, Germana, et al.
Publicado: (2013)

Evaluation of METase-pemetrexed-loaded PEG–PLGA nanoparticles modified with anti-CD133–scFV for treatment of gastric carcinoma
por: Xin, Lin, et al.
Publicado: (2018)

Prognostic Value of CD133 and SOX2 in Advanced Cancer
por: Han, Susu, et al.
Publicado: (2019)

Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review
por: Wen, Lei, et al.
Publicado: (2013)

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
por: Yeh, Chau-Ting, et al.
Publicado: (2009)

CD133 Targeted PVP/PMMA Microparticle Incorporating Levamisole for the Treatment of Ovarian Cancer
por: Wang, Yu-Chi, et al.
Publicado: (2020)

Correction: Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review
por: Wen, Lei, et al.
Publicado: (2014)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Radiosensitivity-Related Genes and Clinical Characteristics of Nasopharyngeal Carcinoma
por: Dai, Yongmei, et al.
Publicado: (2020)

Identification and characterization of CD133(+)CD44(+) cancer stem cells from human laryngeal squamous cell carcinoma cell lines
por: Wang, Jue, et al.
Publicado: (2017)

Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer
por: Liu, Wan-Ting, et al.
Publicado: (2019)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Nasopharyngeal Epstein‐Barr virus DNA loads in high‐risk nasopharyngeal carcinoma families: Familial aggregation and host heritability
por: Zheng, Mei‐Qi, et al.
Publicado: (2020)

Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging
por: Chen, Ya-Wen, et al.
Publicado: (2015)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy
por: Xiao, Andrew Y., et al.
Publicado: (2022)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet
por: Zheng, Shi-Min, et al.
Publicado: (2022)

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
por: Chen, Yao-Li, et al.
Publicado: (2017)

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
por: Rountree, C. Bart, et al.
Publicado: (2011)

Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy
por: Lin, Huan, et al.
Publicado: (2017)

Role of CD133(+) cells in tongue squamous carcinomas: Characteristics of ‘stemness’ in vivo and in vitro
por: Wang, Kai, et al.
Publicado: (2016)

Radiomics in Nasopharyngeal Carcinoma
por: Duan, Wenyue, et al.
Publicado: (2022)

Drosophila Prominin-like, a homolog of CD133, interacts with ND20 to maintain mitochondrial function
por: Wang, Xuexiang, et al.
Publicado: (2019)

Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
por: Zhang, Yanfei, et al.
Publicado: (2013)

Label-free quantitative proteomics of CD133-positive liver cancer stem cells
por: Tsai, Sheng-Ta, et al.
Publicado: (2012)

Isolation, identification and expression of specific human CD133 antibodies
por: Xia, Jing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pk637hkhhr44r6qklc0ei6o923